22 12 16 new investor SE UK

CS MEDICA Signs Deal with a New Distributor for the United Kingdom and Sweden

CS MEDICA A/S (“CS MEDICA” or the” Company”) announces that the company has signed a deal with Cleanpure Scandinavia AB & Cleanpure UK Ltd, who will distribute the entire CANNASEN® portfolio on the Swedish market and the Amazon channels in the United Kingdom as Sweden. 

Lone Henriksen, CEO CS MEDICA, comments
“We are happy to announce that CS MEDICA is enhancing its focus in the Swedish market with our new partnership. Cleanpure is based in Sweden with connections to all relevant stakeholders and already possesses a connection to a sales force, marketing, and logistic setup. The goal is to speed up brand awareness and sales in Sweden to the same level as the Danish market. Regarding Amazon, we want to optimize the Swedish presence and aim for the 2nd largest Amazon platform in Europe, the UK. Still, we especially want to benefit from our approval by MHRA (The Medicines and Healthcare products Regulatory Agency) to kick start the sales in the UK before year-end. Cleanpure is already familiar with the Amazon channel, and with a logistical solution, we see a perfect match”.

Lone Henriksen, CEO CS MEDICA, continues
“We are additionally proud and glad to welcome Cleanpure, which is also one of our investors, who shows confidence in our products to become a strong partner in the business of being a distributor. This way of building a bridge on enhanced market focus, with already well-known stakeholders is something we value highly at CS MEDICA, and hopefully, it will not be the last of its kind”.   

The partnership’s primary focus is the speed-to-market of the CANNASEN® brand and products, which will be within reach in the UK before the end year, and in Sweden starting in 2023.

Nils-Holger Olsson, Founder at Cleanpure, comments
“We see the CANNASEN® products as a great add-on to our current portfolio of innovative products within health and hygiene. We’ve been looking for products with unique technologies to expand our offerings to our customers. CS MEDICA has a competitive advantage in the market with its unique medical devices, cosmetic products, CBD technology, and proven efficacy. Cleanpure can benefit from this distinctive portfolio while growing the CANNASEN® brand with CS MEDICA.”


For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish-based MedTech company committed to improving people’s lives with products that make a difference. We combine science, nature, and passion to deliver innovative alternatives with high efficacy and bioavailability to patients, especially with autoimmune and stress-related diseases.

We research, develop, manufacture, commercialize and brand over-the-counter (OTC) products under pharmaceutical legislation. Currently, 21 products with cannabidiol aimed at autoimmune and stress-related diseases have been developed. The first products reached Danish stores in 2020, and now 9 products are available on the European market at more than 500 points of sale. Another 12 products will be launched before the end of 2024, with 11 patent-pending products. The product line surpasses competing products on the market by being located at the intersection of natural products, science, and cannabinoid technology while being registered under pharmaceutical legislation.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA see  cs-medica.com.